As of Q2 2020, the wholesale acquisition cost of cancer drug Herceptin was around 4,364 U.S. dollars, compared to 3,927 U.S. dollars for the biosimilar Herzuma. Thus, biosimlars were able to rduce the cost between 10 and 22 percent. This statistic illustrates a comparison of the WAC of Herceptin vs biosimilars in the United States, as of Q2 2020.
Comparison of the wholesale acquisition cost (WAC) of Herceptin vs biosimilars in the United States as of Q2 2020
(in U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Amgen. (October 31, 2022). Comparison of the wholesale acquisition cost (WAC) of Herceptin vs biosimilars in the United States as of Q2 2020 (in U.S. dollars) [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/1186607/comparison-wac-herceptin-vs-biosimilars-us/
Amgen. "Comparison of the wholesale acquisition cost (WAC) of Herceptin vs biosimilars in the United States as of Q2 2020 (in U.S. dollars)." Chart. October 31, 2022. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/1186607/comparison-wac-herceptin-vs-biosimilars-us/
Amgen. (2022). Comparison of the wholesale acquisition cost (WAC) of Herceptin vs biosimilars in the United States as of Q2 2020 (in U.S. dollars). Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/1186607/comparison-wac-herceptin-vs-biosimilars-us/
Amgen. "Comparison of The Wholesale Acquisition Cost (Wac) of Herceptin Vs Biosimilars in The United States as of Q2 2020 (in U.S. Dollars)." Statista, Statista Inc., 31 Oct 2022, https://www.statista.com/statistics/1186607/comparison-wac-herceptin-vs-biosimilars-us/
Amgen, Comparison of the wholesale acquisition cost (WAC) of Herceptin vs biosimilars in the United States as of Q2 2020 (in U.S. dollars) Statista, https://www.statista.com/statistics/1186607/comparison-wac-herceptin-vs-biosimilars-us/ (last visited November 21, 2024)
Comparison of the wholesale acquisition cost (WAC) of Herceptin vs biosimilars in the United States as of Q2 2020 (in U.S. dollars) [Graph], Amgen, October 31, 2022. [Online]. Available: https://www.statista.com/statistics/1186607/comparison-wac-herceptin-vs-biosimilars-us/
